Literature DB >> 32237397

[Effect of Dilong on expression of fibrogenic factors TGF-β1 and α-SMA in lung tissue of mice with pulmonary fibrosis].

Hui-Hui Wang1, Yan-Li Meng1, Zhi-Min Yang1, Xiao-Xi Wang1, Hui-Xing Xu1, Wei-Ming Wang1.   

Abstract

The aim of this paper was to investigate the effect of Dilong( geosaurus) on the expressions of fibrotic factors TGF-β1 and α-SMA in bleomycin-induced pulmonary fibrosis mice. The binding ability of Dilong to fibrotic factor TGF-β1 was initially detected by Biacore technology and verified by in vivo pharmacodynamics. A total of 60 SPF C57 mice were randomly divided into 6 groups. Except the blank group( injecting 0. 08 m L·kg-1 sodium chloride in the trachea),the other five groups were given bleomycin( 4 mg·kg-1) to replicate the pulmonary fibrosis model. After 14 days of drug treatment,the expressions of TGF-β1 and α-SMA were detected by Masson staining,immunohistochemistry and RT-PCR. The results of Biacore experiment showed that the extract of Dilong was well bound to TGF-β1 protein in vitro,and the binding value reached 619. 3. Compared with the model group,Masson's results showed that cellulose deposition in high-dose,medium-dose and low-dose Dilong groups decreased to varying degrees. RT-PCR results showed that different doses of Dilong could reduce protein and mRNA expressions of TGF-β1 and α-SMA to a certain extent in a dose-dependent manner. In conclusion,Dilong could delay the process of pulmonary fibrosis by binding to target protein TGF-β1 and inhibiting the expression of α-SMA.

Entities:  

Keywords:  Biacore technology; Dilong(geosaurus); TGF-β1; pulmonary fibrosis; α-SMA

Mesh:

Substances:

Year:  2019        PMID: 32237397     DOI: 10.19540/j.cnki.cjcmm.20190716.402

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  The Effectiveness of Wogonin on Treating Cough Mice With Mycoplasma Pneumoniae Infection.

Authors:  Mingchuan Liang; Yanli Meng; Xiaoxi Wang; Lei Wang; Guixin Tang; Weiming Wang
Journal:  Front Mol Biosci       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.